Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 880-887 , November 2010

Both High and Low Body Mass Indexes are Prognostic Risks in Japanese Patients With Chronic Heart Failure: Implications From the CHART Study

  • Kotaro Nochioka, MD

      Affiliations

    • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Nobuyuki Shiba, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • Corresponding Author InformationReprint requests: Nobuyuki Shiba, MD, PhD, Department of Evidence-based Cardiovascular Medicine and Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aobaku, Sendai 980-8574, Japan. Tel: +81-22-717-7153; Fax: +81-22-717-7156.
    • ,
  • Haruka Kohno, RN

      Affiliations

    • Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Masanobu Miura, MD

      Affiliations

    • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • ,
  • Hiroaki Shimokawa, MD, PhD

      Affiliations

    • Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
    • Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

Received 28 September 2009 ,Revised 11 June 2010 ,Accepted 16 June 2010.

References 

  1. American Heart Association . Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–181
  2. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor of survival in chronic heart failure. Lancet. 1997;349:1050–1053
  3. Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2007;116:627–636
  4. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996–1002
  5. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313
  6. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA(Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51:1775–1783
  7. Kenchaiah S, Sesso HD, Gaziano JM. Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation. 2009;119:44–52
  8. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  9. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A, et al. The prognosis of heart failure in the general population: the Rotterdam Study. Eur Heart J. 2001;22:1318–1327
  10. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9:29–35
  11. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61
  12. Gustafsson F, Kragelund CB, Torp-Persen C, Seibaek M, Burchardt H, Akkan D, et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J. 2005;26:58–64
  13. Cicoira M, Maggioni AP, Latini R, Bariera S, Carretta E, Janosi A, et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur J Heart Fail. 2007;9:397–402
  14. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:13–22
  15. Alla F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Zannad F. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL Study. Am Heart J. 2000;139:895–904
  16. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107–115
  17. Abdulla J, Køber L, Abildstrøm SZ, Christensen E, James WP, Torp-Pedersen C. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J. 2008;29:594–601
  18. Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2002;17:1151–1152
  19. Chang AK, Barrett-Connor E, Edelstein S. Low plasma cholesterol predicts an increased risk of lung cancer in elderly women. Prev Med. 1995;24:557–562
  20. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1–7
  21. Hunt SA. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–82
  22. Swedberg K, Cleland J, Darqie H, Drexler H, Follath F, Komajida M, et al. Task force for the diagnosis treatment of chronic heart failure of the European Society of Cardiology. [Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)]. Eur Heart J. 2005;26:1115–1140
  23. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J. 2004;68:427–434
  24. Shiba N, Nochioka K, Kohno H, Matsuki M, Takahashi J, Shimokawa H, et al. Emerging problem of heart failure practice in Japanese women. Lessons from the CHART Study. Circ J. 2008;72:2009–2014
  25. Shiba N, Matsuki M, Takahashi J, Tada T, Watanabe J, Shimokawa H. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J. 2008;72:173–178
  26. McKee PA, Castelli WP, MaNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446
  27. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
  28. National Kidney Foundation . K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis. 2002;39:S1–266
  29. WHO scientific group . Nutritional anemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37
  30. World Health Organization . Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:6–13
  31. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128:81–88
  32. Ingelsson E, Massaro JM, Sutherland P, Jacques PF, Levy D, D’Agostino RB, et al. Contemporary trends in dyslipidemia in the Framingham heart study. Arch Intern Med. 2009;169:279–286
  33. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481–486
  34. Kuch B, Hense HW, Gneiting B, Döring A, Muscholl M, Bröckel U, et al. Body composition and prevalence of left ventricular hypertrophy. Circulation. 2000;102:405–410
  35. Wang TJ, Parise H, Levy D, Sr D’Agostino RB, Wolf PA, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471–2477
  36. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17:1501–1502
  37. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:391–398
  38. Lauer MS, Anderson KM, Kannnel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231–236
  39. Keaney JF, Larson MG, Vasan RS, Wilson RS, Lipinska I, Corey D, et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003;23:434–439
  40. WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163
  41. Organisation for Economic Co-operation and Development. Health at a Glance 2007 – OECE Indicators. 3.3 Overweight and Obesity. Paris: OECD.
  42. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murqatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72:694–701
  43. Higashi K, Ishikawa T, Ito I, Yonemura A, Shige H, Nakamura H. Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun. 1997;232:728–730
  44. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K, et al. A mutation in the beta3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 1995;215:555–560
  45. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002;502:50230–50236

 See page 886 for disclosure information.

PII: S1071-9164(10)00711-6

doi: 10.1016/j.cardfail.2010.06.413

Journal of Cardiac Failure
Volume 16, Issue 11 , Pages 880-887 , November 2010

Article Tools

* Image Usage & Resolution